Asensus Surgical, Inc. (AMEX:ASXC) Q4 2023 Earnings Call Transcript

Do we do it ourselves and other partnership opportunities for us to leverage other commercial infrastructure to be able to gain adoption. So that’s the commercial part exploratory, but we know there is a need for this, and we have the clear regulatory pathway and also the features relatively well developed. So that’s the reason why we decided that we’re going to go down two pathways and be able to offer these not only for robotic but also stand-alone use.

Swayampakula Ramakanth: Okay. Thanks. Thank you for taking my questions.

Anthony Fernando: Thank you, RK.

Operator: There are no further questions at this time, Mr. Anthony Fernando. Please proceed.

Anthony Fernando: Thank you, operator. Thank you, everyone, for joining today’s call, and we look forward to updating you on our progress throughout the year.

Operator: Ladies and gentlemen, this concludes today’s conference call. Thank you for joining. You may now disconnect.